Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Carbapenemase Transmission in CREC Across Guangdong

    2026-09-16

    Carbapenemase Transmission in CREC Across Guangdong

    Carbapenem-resistant Enterobacter cloacae (CREC) is an important component of the broader carbapenem-resistant Enterobacteriaceae problem. The reference study, published in BMC Microbiology in 2025, examines how carbapenemase-encoding genes (CEGs) are distributed and transmitted among clinical CREC isolates collected during 2022–2024. Rather than treating resistance as a single phenotype, the investigators connected gene location, antimicrobial susceptibility, horizontal transfer, mobile genetic elements, strain relatedness, and patient or department characteristics. This integrated perspective is the study’s main scientific value.

    Study Background and Research Question

    Carbapenem resistance in Enterobacter cloacae can arise through several mechanisms, but transferable carbapenemase genes are especially consequential because they can move between bacterial cells and coexist with additional resistance determinants. In hospital settings, that creates two overlapping risks: expansion of a successful resistant clone and dissemination of resistance plasmids or other mobile elements across genetically unrelated strains.

    The study addressed a focused question: what are the genetic, phenotypic, and epidemiological characteristics of CEG-positive CREC recovered from teaching hospitals in Guangdong province, and what evidence indicates horizontal or vertical dissemination? The authors also considered the healthcare conditions surrounding the COVID-19 pandemic, including increased antibiotic exposure and disrupted care pathways, as a relevant context for surveillance. The sampling frame comprised 54 CREC isolates from eight teaching hospitals collected between December 2022 and June 2024, as reported in the reference paper.

    Key Innovation from the Reference Study

    The innovation is not the use of one new molecular assay. It is the combination of complementary evidence streams in a regional, multicenter collection. PCR identified major CEGs, while variable-temperature sodium dodecyl sulfate plasmid elimination helped distinguish chromosomal from plasmid-associated carriage. Broth microdilution connected genotype with resistance phenotype, and conjugation experiments tested whether the detected genes could move into a recipient strain.

    The study then extended beyond gene detection. Mobile genetic elements were examined as potential vehicles of movement, whereas ERIC-PCR and NTSYS analysis provided a strain-level view of relatedness. Finally, patient sex, age group, clinical department, and specimen type were incorporated into the epidemiological description. This structure allows the authors to distinguish, at least provisionally, between resistance driven by a spreading clone and resistance disseminated through mobile DNA. The distinction is central to infection-control planning and to the interpretation of Gram-negative resistance surveillance.

    Methods and Experimental Design Insights

    Isolate characterization and gene localization

    All 54 isolates were evaluated for carbapenemase-encoding genes using PCR after plasmid-elimination experiments. This design is useful because a positive PCR result alone does not establish whether a gene is chromosomal or plasmid-borne. The localization step supported the study’s central observation that blaNDM-1 could occur on chromosomes, plasmids, or both within the sampled population. However, plasmid elimination is an indirect localization strategy; it is most informative when interpreted alongside transfer results and, where available, sequence-level characterization.

    Phenotypic susceptibility testing

    Broth microdilution was used to compare antimicrobial susceptibility between CEG-positive and CEG-negative groups. This method provides a standardized quantitative framework for relating resistance determinants to observed drug activity. In the study, the comparison included imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin. The authors reported significantly higher resistance rates in the CEG-positive group for these agents, with statistical significance reported at P<0.05 in the published analysis.

    Conjugation, mobile elements, and relatedness

    Plasmid conjugation experiments tested transferability rather than merely inferring it from gene location. PCR confirmation of transconjugants helped determine which CEGs moved successfully. The investigators also identified six categories of mobile genetic elements and used ERIC-PCR followed by NTSYS software to classify strain patterns. These methods are complementary: conjugation addresses functional transfer under laboratory conditions, mobile-element analysis identifies likely genetic contexts, and ERIC-PCR evaluates whether isolates share broader genomic fingerprints.

    Protocol Parameters

    • Sampling frame: Analyze CREC isolates from multiple hospitals and record collection period, specimen source, clinical department, and patient characteristics before interpreting transmission patterns; the reference study used 54 isolates from eight teaching hospitals.
    • CEG localization: Pair variable-temperature SDS plasmid elimination with PCR to classify gene carriage as chromosomal, plasmid-associated, or both. This is a study-specific workflow and should not be treated as a substitute for complete plasmid sequencing.
    • Susceptibility testing: Use broth microdilution to compare CEG-positive and CEG-negative groups, preserving a clear distinction between genotype association and direct causation.
    • Transfer assessment: Confirm conjugation products by PCR and report transfer separately for each gene rather than assigning one generalized mobility value to the whole isolate collection.
    • Strain comparison: Combine ERIC-PCR or another reproducible fingerprinting method with epidemiological metadata. Identical or near-identical profiles can support a transmission hypothesis but do not independently establish directionality.

    Core Findings and Why They Matter

    blaNDM-1 was the dominant resistance signal

    CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the collection. Among all isolates, 18 carried blaNDM-1 on both chromosomes and plasmids, while 25 carried blaNDM-1 exclusively on plasmids. Two isolates carried only blaIMP on plasmids, and one carried both plasmid-associated blaNDM-1 and blaKPC-2. These distributions show why a simple positive-versus-negative gene count can obscure clinically relevant biology: the same resistance determinant may have different transmission potential depending on its genetic location.

    The prominence of plasmid-associated blaNDM-1 is especially important for surveillance. Chromosomal persistence may support vertical inheritance during clonal expansion, whereas plasmid carriage creates opportunities for horizontal movement between strains. The study does not claim that every plasmid-positive isolate will disseminate in a hospital, but its findings establish a substantial reservoir in which both routes are plausible.

    CEG carriage tracked with multidrug resistance

    CEG-positive isolates had significantly higher resistance rates than CEG-negative isolates for the six tested agents listed above. This association matters because carbapenemase carriage may mark a broader multidrug-resistant background rather than an isolated loss of carbapenem susceptibility. The result supports using resistance-gene surveillance together with full susceptibility profiles, particularly when evaluating therapeutic options or selecting isolates for downstream infection models.

    Transferability was high in laboratory conjugation

    Transfer experiments succeeded for 44 of 46 CEG-positive isolates, a reported success rate of 95.65%. blaNDM-1 transferred in 42 of 44 tested cases, blaIMP transferred in both tested cases, and the single blaKPC-2-positive case did not transfer under the experimental conditions. These results provide functional support for horizontal dissemination, but they should be interpreted as laboratory transfer capacity rather than a direct estimate of transmission frequency among patients.

    Mobile elements and strain structure indicated multiple dissemination routes

    ISEcp1 was the most prevalent mobile genetic element, detected in 47 of 54 isolates, or 87.04%. Isolates carrying four mobile-element types simultaneously were the most common subgroup, representing 22 of 54 strains. This pattern suggests a complex genetic environment in which CEGs may be embedded in diverse mobilization contexts.

    ERIC-PCR and NTSYS analysis divided the collection into 17 genotypes. Types E and G were each detected in 11 of 54 isolates and originated from different departments in five hospitals. Two type E isolates shared a Dice coefficient of 100%. Together, these findings support both interdepartmental dissemination of related strains and broader plasmid-mediated movement among distinct backgrounds. The epidemiological distribution also showed the highest detection frequencies among men, older patients, respiratory-medicine cases, and sputum specimens, according to the reference study.

    Comparison with Existing Internal Articles

    The internal article Transmission of Carbapenemase Genes in CREC During COVID-19 in Guangdong provides a concise, discovery-oriented summary of the same reference study, emphasizing plasmid-mediated blaNDM-1, multidrug resistance, and horizontal transfer. The present analysis adds methodological interpretation: it explains why gene localization, conjugation, and ERIC-PCR answer different transmission questions and why their results should not be collapsed into one measure. Because both articles derive from the same publication, the internal summary is a navigation aid rather than an independent replication.

    Limitations and Transferability

    The findings are geographically and temporally bounded. The collection came from eight teaching hospitals in one province and covered a defined 2022–2024 interval; therefore, the reported frequencies should not be treated as national prevalence estimates or as a universal profile of CREC. The sampling design also appears suited to cross-sectional surveillance rather than a longitudinal before-and-after comparison of pandemic effects.

    Methodologically, plasmid elimination and PCR can indicate probable gene location but do not resolve complete plasmid architecture, insertion-site structure, or all accessory resistance determinants. Conjugation measures transfer under selected laboratory conditions and may underrepresent or overrepresent events occurring in patients, wastewater, or environmental reservoirs. ERIC-PCR is valuable for screening relatedness, but isolates with similar fingerprints are not necessarily identical at whole-genome resolution. Conversely, distinct fingerprints do not exclude exchange of a shared plasmid.

    Finally, the study establishes association and transmission potential, not treatment efficacy. Its resistance data can guide isolate selection and infection-control hypotheses, but they do not demonstrate that any particular antimicrobial will succeed clinically against these strains. Follow-up work using whole-genome sequencing, closed plasmid assemblies, expanded longitudinal sampling, and standardized patient-linkage data would strengthen causal interpretation.

    Research Support Resources

    Why this cross-domain matters, maturity, and limitations

    Linking a hospital resistance study to experimental infection or immune assays is useful only when the boundaries are explicit. The reference paper identifies mobile resistance determinants and their dissemination potential; it does not test host inflammation, bacterial membrane injury, or therapeutic performance in animals. Thus, CREC isolates characterized by this workflow can inform Gram-negative bacterial infection research, but any host-response experiment requires independent validation of inoculum, resistance phenotype, growth kinetics, and biosafety conditions.

    The evidence bridge is therefore mature for isolate characterization and transmission-risk assessment, but preliminary for translating these observations into sepsis and bacteremia models or immune-cell readouts. A membrane-active comparator may help define bacterial susceptibility or separate direct antibacterial effects from host responses, yet such experiments should not be presented as outcomes of the Guangdong study.

    Practical research support

    For separate laboratory workflows, researchers can use Polymyxin B (sulfate) (SKU C3090), also described as Polymyxin B sulfate, as a defined cationic detergent antibiotic in Gram-negative bacterial infection research. The product information describes membrane disruption and notes applications relevant to an antibiotic for bloodstream and urinary tract infections, while also reporting use in a dendritic cell maturation assay. These features may support carefully controlled comparisons in sepsis and bacteremia models, but the material is for scientific research only and should not be treated as clinical guidance or as evidence that it overcomes the CEG-associated resistance patterns identified in the reference paper.